Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06615973 · ClinicalTrials.gov registry record

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

A clinical trial of Stroke and Vascular Diseases, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Recruiting
Registry status
450
Enrollment target
1
Study location

NCT06615973: Recruiting study of Stroke and Vascular Diseases, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT06615973 is a study of Stroke and Vascular Diseases that is actively recruiting participants, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 450 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06615973, a study of Stroke and Vascular Diseases, is actively recruiting participants, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

RECRUITING
Registry status
450 participants
Enrollment target
1
Study location

Study Summary

Background: Stroke is the fifth leading cause of death in the United States. It is also a leading cause of disability. More than 70% of people who survive strokes have mental impairment or dementia. Medical factors, such as the severity of the stroke, affect whether a person will have mental impairment afterward. But social factors, such as education and ethnicity, seem to play a role as well. Researchers want to learn more about how social and lifestyle factors affect a person s chances of maintaining mental functions after a stroke. Objective: To better understand how social and lifestyle factors affect the risk of mental impairment after a stroke. Eligibility: People aged 18 years and older who had a stroke and a brain scan while they were enrolled in NIH Study 01N0007 (Natural History of Stroke Study). Design: Participants will have 1 study visit, by telephone. The call will last about 45 minutes. Participants will talk about their health since their stroke. They will answer questions about themselves. Topics will include: * Their race * Education * Ethnicity * Employment * Marital status * Residence address * Recent health history * Medical insurance They will have tests of their memory, attention, and language skills. They will repeat numbers and words forward and backward. Researchers will look at the data and imaging scans collected during participant s enrollment in NIH Study 01N0007. This data will include: * The hospital that first saw the participant at the time of their stroke. * The type of imaging that was first used then. * The primary diagnosis at admission. * Other medical details.

Primary Outcome

Will use linear regression models to assess association between core infarct volume and post stroke function (as defined by NIHSS) as modified by SDOH

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2026-03-26
Est. Completion 2027-02-01

What NCT06615973 shows while recruiting

NCT06615973 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower).

The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT06615973 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06615973 about?

NCT06615973 is a clinical study titled "Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke". Background: Stroke is the fifth leading cause of death in the United States. It is also a leading cause of disability. More than 70% of people who survive strokes have mental impairment or dementia. Medical factors, such as the severity of the stroke, affect whether a person will have mental impair...

What is the current status of trial NCT06615973?

This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2026-03-26. Estimated completion is 2027-02-01.

What conditions does trial NCT06615973 study?

This clinical trial studies the following conditions: Stroke, Vascular Diseases, Brain Disease, Cerebrovascular Disorder.

Who is sponsoring clinical trial NCT06615973?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06615973 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06615973's enrollment target sits among peer trials

450 61st of 454 higher than 393 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00515060 · 450 participants

    Psychophysical Studies of Cancer Therapy Pain

  • NCT01257269 · 450 participants

    Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

  • NCT03047161 · 450 participants

    Electrophysiology of Fetal Arrhythmia

  • NCT03269630 · 450 participants

    New Orleans Pulmonary Hypertension Biobank

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06615973, the US trial registry maintained by the National Library of Medicine. NCT06615973 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.